About Blis Technologies
Blis Technologies is a publicly listed company based in Dunedin (New Zealand) founded in 2000. Oral probiotic supplements with Streptococcus salivarius strains are provided. The company has 33 employees. Its chief executive, as recorded, is Brian Watson. Blis Technologies offers products and services including BLIS K12™, BLIS M18™, BLIS Q24™, BLIS Q24™ Live Probiotic Serum, and BLIS K12™ Throat Health Lozenge. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Probiotics.
Company details
Blis Technologies was founded in 2000 in Dunedin, New Zealand, and operates within the probiotics sector. Oral supplements, including BLIS K12 and BLIS M18, are developed using strains of Streptococcus salivarius. These strains produce bacteriocin-like inhibitory substances that target harmful bacteria in the oral cavity. Distribution occurs through health and wellness channels, focusing on oral health maintenance.
- Headquarters Dunedin, New Zealand
- Employees 33
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website blis.co.nz
- Social LinkedIn Facebook
- Legal Name Blis Technologies Limited
- Annual Revenue$8.41 M (USD)16.01as on Mar 31, 2026
- Net Profit$396.62 K (USD)-17.42as on Mar 31, 2026
- EBITDA$619 K (USD)6.9as on Mar 31, 2026
- Employee Count33
Products & Services of Blis Technologies
Blis Technologies offers a comprehensive portfolio of products and services, including BLIS K12™, BLIS M18™, BLIS Q24™, BLIS Q24™ Live Probiotic Serum, and BLIS K12™ Throat Health Lozenge.
Probiotic for throat health and immunity support.
Probiotic for teeth and gums health maintenance.
Probiotic for skin health and balance.
Serum incorporating live probiotics for skin improvement.
Lozenge providing throat health benefits via probiotics.
People of Blis Technologies
1 people are tracked at Blis Technologies (1 in leadership); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
Brian Watson | CEO | Leadership |
Complete people profiles for Blis Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Blis Technologies
Blis Technologies is a publicly listed company on the NZX with ticker symbol BLT in New Zealand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Aug 2001
- Listed onNZX: BLT
- Listed entityBLIS Technologies Limited
- Exchange sectorHealth technology
- ISINNZBLTE0002S8
- Share price0.03 NZD (+3.7% on the day) · 2026-10-14
- Market capitalisation34,541,145.00 NZD
- Price to earnings56.0
- EPS (diluted, trailing year)0.00 NZD
- Volume (last session)261,786
Financials of Blis Technologies
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 14.7M NZD | 692,000 NZD | 1.1M NZD |
| 2024 | 12.6M NZD | 838,000 NZD | 1.0M NZD |
| 2023 | 11.5M NZD | 646,000 NZD | 791,000 NZD |
| 2022 | 10.2M NZD | -1.4M NZD | -624,000 NZD |
| 2021 | 8.8M NZD | -2.7M NZD | -2.6M NZD |
Detailed financial statements for Blis Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Blis Technologies
The website of Blis Technologies (blis.co.nz) receives about 4.5K visits a month.
- Monthly visits4.5K
▼ 17.3% vs previous month
Websites whose visitors overlap most with Blis Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bioinfotools.com | bioinfotools.com | 100% | – | ||
| abacusbio.com | 100% | View details | |||
zenithtechnology.co.nz | zenithtechnology.co.nz | 100% | #10,605,611 | – | |
a2corporation.com | a2corporation.com | 100% | – | ||
fecpak.com | fecpak.com | 100% | #11,620,834 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Blis Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Blis Technologies
Complete news archive for Blis Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blis Technologies
Blis Technologies was founded in 2000.
Blis Technologies is headquartered in Dunedin, New Zealand. It is registered at Dunedin, Otago, New Zealand.
Brian Watson is the CEO of Blis Technologies, as recorded in our data.
Blis Technologies has 33 employees.
Annual revenue of Blis Technologies is $8.41M as on Mar 31, 2026.
Blis Technologies was founded in 2000 in Dunedin, New Zealand, and operates within the probiotics sector. Oral supplements, including BLIS K12 and BLIS M18, are developed using strains of Streptococcus salivarius. These strains produce bacteriocin-like inhibitory substances that target harmful bacteria in the oral cavity. Distribution occurs through health and wellness channels, focusing on oral health maintenance.
Blis Technologies offers BLIS K12™, BLIS M18™, BLIS Q24™, BLIS Q24™ Live Probiotic Serum, and BLIS K12™ Throat Health Lozenge.
Yes, Blis Technologies is publicly traded on NZX under the ticker symbol BLT.